MSK-ACCESS
Institutional ultra-deep cfDNA sequencing assay for noninvasive genomic profiling and disease monitoring; current panel covers 146 genes.
- Developer
- Memorial Sloan Kettering Cancer Center
- Intended use
- Other
- Cancer scope
- Not reported
- Specimen
- Peripheral whole blood
- Molecular modality
- DNA mutation
- Current version
- MSK-ACCESS current 146-gene configuration (2026)
- Evidence context
- 1 structured studies · 0 indexed performance results · 2 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.